Background: Endoscopic sinus surgery (ESS) is considered after medical therapy failure of chronic rhinosinusitis (CRS). The balloon sinuplasty dilates the natural ostium without moving mucosa or bone. It still lacks evidence from randomized controlled trials. The aim of this retrospective controlled study was to compare the symptom outcomes after maxillary sinus surgery with either the ESS or the balloon sinuplasty technique. No previous or additional sinonasal operations were accepted.
C hronic rhinosinusitis (CRS) is a versatile, multifactorial immunologic disease of the nose and paranasal sinuses with ϳ10% prevalence. 1 CRS is diagnosed by its typical symptoms lasting Ͼ12 weeks and computed tomography (CT) scan and/or endoscopic changes. 2 Its impact on the quality of life (QoL) is comparable with other chronic diseases. 1 Several diseases have been reported to coexist with CRS by partly unknown mechanisms: asthma, aspirin sensitivity, atopy, chronic rhinitis, depression, anxiety, fatigue, fibromyalgia, immunodeficiency, cystic fibrosis, and primary ciliary dyskinesia. [3] [4] [5] It has been shown that biological and chemical agents associate with work-related asthma and occupational exposure might cause 10-20% of adult-onset asthma. [6] [7] [8] However, only few studies address the influence of occupational exposure on CRS. 9, 10 Basic management of CRS is composed of nasal saline irrigations and corticosteroids. Depending on the related comorbidities and the hyperinflammatory or infective nature of the exacerbations, additional treatment might be used. 2 Endoscopic sinus surgery (ESS) is considered during recalcitrant and difficult-to-treat CRS. ESS might decrease inflammation by re-storing the mucociliary clearance through the natural ostia. 2 Uncontrolled studies have shown QoL improvement after ESS. 5 Although not proven to be superior to conservative therapy, ESS seems to at least partially relieve symptoms and/or decrease inflammatory findings. 2, 11, 12 The recurrence rate of CRS exacerbations is high, especially in patients who have nasal polyps, asthma, and/or aspirin sensitivity or occupational exposure. 2, 10, 13 The principal behind balloon sinuplasty differs from that of ESS. 14 The guide wire and the balloon catheter are advanced into the sinus ostium. The balloon pressure varies from 8 to 12 bar and is maintained for only a few seconds, causing the thin bony walls of the ostia to compress or fracture, resulting in a wider passage to the sinus. The disadvantages of the procedure are the lack of knowledge on its long-term effects, the costs of the disposable instruments, and its technical limitations in the ethmoidal area or in removing atypical mucosa. 15 Several uncontrolled and three controlled studies have suggested balloon sinuplasty to be a safe and effective method. [15] [16] [17] [18] [19] However, the limitations of these studies are the heterogeneity of patients and procedures, which makes the conclusions difficult to draw.
In this retrospective, controlled study, adult CRS patients underwent primary bilateral maxillary sinus procedures, with either the balloon sinuplasty or the ESS technique. The aim of this study was to compare, using a questionnaire, the number of exacerbations and the change in symptoms between the procedures.
MATERIALS AND METHODS

Patients
The Ethical Committee of Pirkanmaa Hospital District, Tampere, Finland, has approved the study plan. Informed consent was obtained from all of the patients. The inclusion criteria were based on the medical records: CRS diagnosis and operative indications fulfilled European position paper on rhinosinusitis and nasal polyps recommendations and surgical procedure to maxillary sinuses. 2 The exclusion criteria were age Ͻ15 years; previous or concomitant additional sinonasal surgery; unilateral CRS; endoscopic signs of nasal polyposis (grade Ն2) during surgery; a history of aspirin sensitivity; and
chronic bronchitis, cystic fibrosis, primary ciliary dyskinesia, tumor, or another disease with a severe impact on general immunity. 20 The balloon sinusotomy group consisted of all CRS patients (n ϭ 103) that underwent balloon sinusotomy at two private clinics (Terveystalo Health care OYJ of Finland, Tampere, Finland, and Koskiklinikka Tampereen Lääkärikeskus Oy, Tampere, Finland) between 2008 and 2010. The control ESS group consisted of all CRS patients (n ϭ 105) who underwent uncinectomy and middle meatal antrostomy, at Päijät-Häme Central Hospital, Lahti, Finland, during 2008-2010. Forty-five patients in the ESS group and 40 patients in the balloon group met the inclusion criteria and received a letter with a questionnaire. The patients (n ϭ 14) that had Ͻ18 months follow-up were contacted by telephone, on average, 1 year later and were given another questionnaire.
Operations
Only patients having bilateral maxillary sinus operations were included in the study. Thus, previous or concomitant surgeries, such as septoplasty or anterior ethmoidectomy or resection of bullous turbinate, were not accepted. The balloon sinuplasty was performed by one according to the manufacturerЈs instructions (Acclarent, Inc., a member of Johnson & Johnson Co., New Brunswick, NJ). No pack was placed. No postoperative debridement was performed. Two authors (J.M., 80%, and J.S., 20%) performed uncinectomy and middle meatal antrostomy in the ESS group. Two-thirds of the lower part of the uncinate process was cut by the backbiting forceps. The maxillary ostium was enlarged to posterior-inferior direction to double its diameter. A small pack (3.5 ϫ 0.6 ϫ 1.2 cm, Merocel; Medtronic-Xomed, Jacksonville, FL) was placed into the middle meatus for 24 hours. Debridement control was approximately 4 weeks postoperatively.
Questionnaires
The questionnaire asked about the patient's medical history such as the presence of doctor-diagnosed allergic rhinitis, asthma, and previous nasal polyps; the presence of nonsteroidal anti-inflammatory drug-induced wheezing; smoking habits; medication; duration of CRS symptoms; and previous sinonasal operations. The regularly Table 1 The questions that belonged to the VAS questionnaire evaluating how the operation changed symptoms (ranging from 0 ͓cm͔, "recovered totally," to 10 ͓cm͔ "became as worse as it can be)
Mean of VAS Scores
VAS Questionnaire
Asked Bilaterally , and prostate hyperplasia (B ϭ 1, E ϭ 1). The work exposure was evaluated according to reported current occupation and characterization of work place, characterization of substances and places of putative past or current exposure to poor indoor air quality, and by the question, "Has a doctor ever suspected an occupational hypersensitivity?" "If yes, please list the suspected substances." The positive job exposure group was determined according to international categorization of high-risk occupations. 6, 8 Two more patients (1 in balloon sinuplasty and 1 in the ESS group) reporting severe occupational exposure to poor indoor air quality were added to this group as well. The main substances causing job exposure were bioaerosols (B ϭ 2 patients, E ϭ 2 patients), agricultural organic particles (B ϭ 3,
The changes of symptoms were evaluated by using the visual analog scale (VAS) with the question, "How much did the following symptoms change after the operation?" The value 0 (cm) indicated "recovered totally," and value 10 (cm) indicated "became as worse as it can be." Twenty-two questions were similar to those of the 22-item Sino-Nasal Outcome Test (Table 1) . 2 In addition, 12 questions concerning general health or CRS relating/resembling symptoms were asked ( Table 1 ). The bilaterally existing symptoms were asked separately from each side. Statistical evaluation was performed with eight VAS subscales (Table 1) . CRS exacerbations were evaluated by the following question: "How many acute sinusitis treated by prescribed antibiotics have you had during the past year?" "How many maxillary sinus punctures/sinus x rays/ultrasonographys of maxillary sinuses has a doctor performed on you during the past year?"
Statistical Analysis
Statistics were performed with SPSS Base 16.0 Statistical Software Package (SPSS, Chicago, IL). The results were confirmed by a professional statistician. The nonparametric Fisher's exact test and Kruskal-Wallis and Mann Whitney U tests were used for comparisons of groups. A two-tailed value of p Ͻ 0.05 was considered significant in all tests.
RESULTS
Patient Characteristics
Twenty-nine patients in the ESS group and 24 patients in the balloon sinusotomy group responded. The groups were identical in all demographic variables ( Table 2 ). There was a high prevalence of self-administered previously doctor-diagnosed nasal polyps (41% in the ESS group and 21% in the balloon sinusotomy group), although none of the patients were having intraoperative endoscopic signs of nasal polyps (Table 2) . Preoperative sinus CT scans were available in Table 2 ). In addition, preoperative sinus magnetic resonance imaging scans were from one patient in the balloon sinuplasty group. The Lund-Mackay scores on each side were retrospectively evaluated from the CT (or magnetic resonance imaging) scans. There were no differences between the groups in the Lund-Mackay (LM) scores of the maxillary sinus, whereas the LM total scores and the LM sore of the right ostiomeatal complex differed significantly ( Table 2 ). The frontal sinuses were absent in three patients in the balloon sinuplasty group.
Exacerbations
The balloon sinuplasty group reported a higher number of doctorperformed maxillary sinus punctures, ultrasonography examinations, and prescribed antibiotic courses for acute sinusitis during the last 12 months, which differed statistically significantly from the ESS group (Table 3 ). The number of performed sinus x rays during the past 12 months did not differ between the treatment groups (Table 3 ).
Visual Analog Scale
The mean of all of the VAS scores was 3.6 in all patients (3.7 in the balloon sinuplasty group and 3.5 in the ESS group). This indicated an average improvement of 28% of all the asked symptoms. The VAS scores for the change of symptoms and the eight VAS subscales did not differ between the balloon sinuplasty and ESS groups (p Ͼ 0.05, Fig. 1 ). The greatest improvement was achieved in the VAS scores concerning the change in nasal congestion, discharge, and facial pressure. This improvement was also equal in both groups (Fig. 1) .
The Influence of CRS Comorbidities. Allergic rhinitis and previously diagnosed nasal polyps did not have an influence on the VAS subscale values (p Ͼ 0.05). Asthma and current job exposure contributed to the elevated VAS subscales, indicating less improvement compared with patients without these risk factors (Table 4 ). Interestingly, this was only found in the balloon sinuplasty group but not in the ESS group (Table 4 ). The comparison of the two operation techniques in the asthma or job exposure subgroups did not bring differences of statistical importance (p Ͼ 0.05). However, when observing a patient subgroup having a combination of current job exposure and at least one CRS co morbidity (e.g., asthma/previous nasal polyps/allergic rhinitis), several VAS subscale values were significantly lower in the ESS group compared with the balloon sinuplasty group, indicating greater symptom reduction after ESS than after balloon sinuplasty ( Table 5 ; Fig. 1 ).
The Influence of Other Diseases. The patients who were regularly taking medication for at least one additional disease (e.g., other than CRS/allergic rhinitis/asthma) had significantly lower VAS subscale values, indicating a greater improvement in symptoms compared with patients without additional disease(s) ( Table 4 ). Interestingly, this was found only in the ESS group but not in the balloon sinuplasty group ( Table 4 ). The comparison of the two operation techniques in this subgroup did not bring statistically significant differences to the VAS subscale values (p Ͼ 0.05).
The Influence of Other Factors. Female gender contributed significantly to lower VAS scores, but only in subscales of "emotions" and "general health" (p ϭ 0.006 and p ϭ 0.050, respectively). This was equally found in the balloon sinuplasty and the ESS groups. The VAS subscales were not influenced by the following patient factors: age, reported duration of CRS symptoms, length of the postoperative follow-up period, or alcohol consumption (p Ͼ 0.05). Similarly, the VAS subscales were not influenced by smoking habits, previous
Figure 1. (A) Comparison of mean visual analog scale (VAS) scores of change in symptoms between balloon sinuplasty and ESS groups in all patients and (B) in a subgroup having job exposure and asthma/previous nasal polyps/allergic rhinitis. The x-axis represents mean VAS scores change
in symptoms (range, 0-10). We used the question "How much did the following symptoms change after the operation?" The value 0 (cm) indicated "recovered totally" and value 10 (cm) indicated "became as worse as it can be." The y-axis represents the eight subscales that were the mean values of group-specific symptoms as shown in Table 1 . Statistically significant differences are shown by asterisks (*p Ͻ 0.05) by Mann Whitney U test. 
DISCUSSION
This study was to compare balloon sinuplasty and ESS (uncinectomy and middle meatal antrostomy) in adult patients with nonpolypous CRS, and with no previous sinonasal operations. The improvement of the VAS values of the change in symptoms for all of the patients was similar for both techniques. The average improvement after ESS was 17%, measured by the CRS survey score, which is in accordance with our findings of 28% improvement. 21 QoL measures how an illness interferes with a patients' day-to-day life, whereas exacerbation rate might be better in estimating to what extent CRS is under control. 22 We found that the number of patient-reported, doctor-diagnosed postoperative acute sinusitis, indicating exacerbation rate, was lower after ESS than after balloon sinuplasty. Currently, several patient series studies and three controlled studies exist on balloon sinusotomy, suggesting it as a safe method and comparable with ESS. In a prospective randomized trial, in which heterogeneous operation techniques were tolerated, balloon dilation of the frontal recess reduced the VAS symptom scores equally to the ESS procedure 12 months postoperatively. 18 In a retrospective setup, with a short follow-up period, and a variation in the (re)operated sinuses, a significant reduction of symptom scores was achieved equally with both the ESS and the balloon sinuplasty techniques, but the patient satisfaction was slightly better in the balloon sinusotomy group. 16 In a prospective nonrandomized pediatric CRS study, a significantly younger children group with adenoidectomy had improvement similar to the older children group who underwent balloon sinusotomy. 17 In a preliminary study with a small number of patients, balloon sinuplasty with polypectomy was as effective as ESS with polypectomy. 23 It has been suggested that balloon sinuplasty may potentially inadvertently impair mucociliary clearance of the sinuses through effects on secondary drainage pathways. 24 The subset observation in our study suggests that patients with asthma or job exposure might experience less symptom reduction after balloon sinuplasty but not after ESS, compared with patients without asthma or without job exposure. Moreover, if the patient had both job exposure and at least one CRS comorbidity (asthma/previous nasal polyps/allergic rhinitis), he/she might benefit more from ESS than balloon sinuplasty. Although we and others have previously shown that a high mucosal eosinophilia might predict reduced postoperative outcomes, Badaai et al. showed that the presence of asthma would not be a negative or positive predictor for the total healthrelated QoL outcome. 5, 21, 25, 26 This finding is supported by observations in the present study that the symptoms of asthma patients improved equally to nonasthmatic patients, but only in the ESS group. Irritant exposure has been investigated less during CRS, whereas it is known to influence asthma onset and exacerbations. 6, 7, 9 A recent study shows that occupational exposure might be a risk factor for the occurrence and recurrence of CRS. 10 Chronic infection or other factors might play a role in CRS pathogenesis, especially in patients with respiratory comorbid diseases and occupational exposure. Others have studied that biofilms are associated with refractory CRS and revision ESS. 27, 28 Zhang et al. also observed that bacterial biofilms and asthma associate strongly with revision ESS. 29 The overexpression of atopic and occupational risk factors during difficult-totreat CRS supports the importance of Allergic Rhinitis and Its Impact on Asthma conceptual work. 30 Interestingly, we found that the patients with other additional disease(s) than CRS-related respiratory comorbidities had greater improvement of symptoms, but, again, only in the ESS group. This is in accordance with previous findings that depression patients, as well as elderly patients that usually have multiple diseases and medications, have good ESS outcomes if they do not have chronic diseases severely affecting general immunity. 31, 32 Female patients had better improvement in the VAS subscale scores of emotions and general health, independently of the operation technique. In contrast, Smith et al. showed that postoperative QoL was adversely affected by female sex. 33 Intraoperative nasal polyps and Samter's triad were medical record-based exclusion criteria in our study; however, 19 patients reported previous doctor-diagnosed nasal polyps, and two patients reported nonsteroidal anti-inflammatory drug-induced wheezing symptoms. The possible explanation might be the resolution of nasal polyposis and underdiagnosed ASA sensitivity.
Multiple comments can be made on the drawbacks of this retrospective controlled study. The sample size was low, especially related to the subgroup analyses. We used a nonvalidated questionnaire on the VAS scores and were not able to observe the differences in the preoperative symptoms. Because there is still no evidence-based approval in public health care of Finland, balloon sinuplasty was performed in the private sector, whereas ESS was performed in the public sector. Thus, there might have been some differences in the social background of the patients, which might have also influenced the results. In the retrospective evaluation, the preoperative radiological findings of all sinuses were found to be slightly milder in the balloon sinusotomy group. This could possibly indicate that CRS might have been less severe in the balloon sinuplasty group and that a selection bias might have occurred. On the other hand, the groups were identical in the preoperative opacification of maxillary sinuses, in the duration of CRS symptoms, and in other medical history factors. The acute exacerbations after surgery were treated equally at public and private sectors in both groups.
CONCLUSION
In our study, ESS was slightly better in terms of the number of acute exacerbations. A better reduction of symptoms was achieved by the ESS procedure compared with balloon sinuplasty in patients with occupational or CRS-related risk factors, as well as in patients with other disease(s) than known CRS-related comorbidities. A prospective randomized controlled study with an increased number of patients is warranted.
